Deafness_Isolated

Gene: ATP11A

Green List (high evidence)

ATP11A (ATPase phospholipid transporting 11A)
EnsemblGeneIds (GRCh38): ENSG00000068650
EnsemblGeneIds (GRCh37): ENSG00000068650
OMIM: 605868, Gene2Phenotype
ATP11A is in 6 panels

3 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

PMID 35278131 reports three additional families, including segregation in a large pedigree.
Created: 26 May 2023, 12:29 a.m. | Last Modified: 26 May 2023, 12:29 a.m.
Panel Version: 1.43

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Deafness, autosomal dominant 84, MIM# 619810; Auditory neuropathy, autosomal dominant 2, MIM# 620384

Publications

Chern Lim (Victorian Clinical Genetics Services)

I don't know

PMID: 36300302:
- A family with non-syndromic autosomal-dominant auditory neuropathy/auditory synaptopathy. The same family previously published in PMID: 28601886 Lang-Rogh 2017.
- 5500 bp deletion involving the last coding exon of both RefSeq annotated ATP11A isoforms.
- Present in 10 affected individuals from a multi-generational family, absent in 2 unaffected family members tested.
- RNA studies showed ATP11A deletion allele did not undergo NMD, and led to an inclusion of a pseudoexon of 117 bp size, resulting in a novel 38 amino-acid spanning C-terminus of the mutant protein.
- Mutant ATP11A had normal subcellular localisation.
- Studies in mice showed ATP11A protein is expressed in mouse inner ear, conditional Atp11a ko mice showed age-progressive dysfunction or loss of spiral ganglion neurons.
Created: 3 Nov 2022, 3:56 a.m. | Last Modified: 3 Nov 2022, 3:56 a.m.
Panel Version: 1.37

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Deafness, autosomal dominant 84 (MIM#619810)

Publications

Variants in this GENE are reported as part of current diagnostic practice

Paul De Fazio (Victorian Clinical Genetics Services)

I don't know

Three families described with autosomal dominant non-syndromic deafness:

A Canadian family of European ancestry was described with a novel variant affecting splicing of the 3'UTR of one isoform of ATP11A. RNA studies showed the retention of 153bp of intronic sequence in the 3'UTR. Other isoforms may be variably affected. The variant is deep intronic in the two RefSeq transcripts. Variant was present in 17 affected and absent in 19 unaffected individuals.

Two Jewish Israeli families, one originating from Uzbekistan and one from Afghanistan, described with the same splice variant. RNA studies confirmed extension of the penultimate exon and a PTC (not NMD predicted). Variant segregated in 8 affected individuals, absent from 3 tested unaffected individuals.
Sources: Literature
Created: 7 Apr 2022, 1:29 a.m. | Last Modified: 7 Apr 2022, 1:37 a.m.
Panel Version: 1.25

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Deafness, autosomal dominant 84 MIM#619810

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
Phenotypes
  • Deafness, autosomal dominant 84, MIM# 619810
  • Auditory neuropathy, autosomal dominant 2, MIM# 620384
OMIM
605868
Clinvar variants
Variants in ATP11A
Penetrance
None
Publications
Panels with this gene

History Filter Activity

26 May 2023, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: ATP11A were changed from Deafness, autosomal dominant 84 MIM#619810 to Deafness, autosomal dominant 84, MIM# 619810; Auditory neuropathy, autosomal dominant 2, MIM# 620384

26 May 2023, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: ATP11A were set to 35278131

26 May 2023, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: atp11a has been classified as Green List (High Evidence).

7 Apr 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: atp11a has been classified as Amber List (Moderate Evidence).

7 Apr 2022, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: ATP11A was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

7 Apr 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: atp11a has been classified as Amber List (Moderate Evidence).

7 Apr 2022, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Paul De Fazio (Victorian Clinical Genetics Services)

gene: ATP11A was added gene: ATP11A was added to Deafness_Isolated. Sources: Literature Mode of inheritance for gene: ATP11A was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: ATP11A were set to 35278131 Phenotypes for gene: ATP11A were set to Deafness, autosomal dominant 84 MIM#619810 Review for gene: ATP11A was set to AMBER gene: ATP11A was marked as current diagnostic